Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Non-Current Assets: 2020-2024

Historic Non-Current Assets for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $1.4 million.

  • Biofrontera's Non-Current Assets fell 36.78% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 36.78%. This contributed to the annual value of $1.4 million for FY2024, which is 71.16% down from last year.
  • Latest data reveals that Biofrontera reported Non-Current Assets of $1.4 million as of FY2024, which was down 71.16% from $4.9 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Non-Current Assets ranged from a high of $7.7 million in FY2022 and a low of $1.4 million during FY2024.
  • Moreover, its 3-year median value for Non-Current Assets was $4.9 million (2023), whereas its average is $4.7 million.
  • As far as peak fluctuations go, Biofrontera's Non-Current Assets spiked by 49.01% in 2021, and later crashed by 71.16% in 2024.
  • Biofrontera's Non-Current Assets (Yearly) stood at $4.6 million in 2020, then spiked by 49.01% to $6.8 million in 2021, then increased by 13.92% to $7.7 million in 2022, then tumbled by 37.28% to $4.9 million in 2023, then plummeted by 71.16% to $1.4 million in 2024.